News

b

b

Current News in Drug Discovery

RSS Nature Reviews Drug Discovery
  • Creating an AI-first drug discovery engine September 13, 2024
    Nature Reviews Drug Discovery, Published online: 13 September 2024; doi:10.1038/d41573-024-00149-6Najat Khan — Chief R&D Officer and Chief Commercial Officer at Recursion — discusses the proposed merger of Recursion and Exscientia.
    Asher Mullard
  • Author Correction: Antimalarial drug discovery: progress and approaches September 13, 2024
    Nature Reviews Drug Discovery, Published online: 13 September 2024; doi:10.1038/s41573-024-01045-9Author Correction: Antimalarial drug discovery: progress and approaches
    Jair L. Siqueira-Neto
  • Targeting cytokine networks in neuroinflammatory diseases September 11, 2024
    Nature Reviews Drug Discovery, Published online: 11 September 2024; doi:10.1038/s41573-024-01026-yDysregulated cytokine networks are important in the pathogenesis of neuroinflammation. This Review discusses targeting cytokines and their receptors in non-infectious central nervous system inflammatory diseases such as multiple sclerosis and neurosarcoidosis, as well as in the neurotoxic adverse events that can be triggered by cancer immunotherapy.
    Burkhard Becher
  • Upcoming market catalysts in Q4 2024 September 10, 2024
    Nature Reviews Drug Discovery, Published online: 10 September 2024; doi:10.1038/d41573-024-00148-7Upcoming market catalysts in Q4 2024
    Sarina Harper
  • RIPTACs expand anticancer target space September 9, 2024
    Nature Reviews Drug Discovery, Published online: 09 September 2024; doi:10.1038/d41573-024-00146-9RIPTACs expand anticancer target space
    Katie Kingwell
  • PPAR agonists provide new treatment options for inflammatory liver disease September 9, 2024
    Nature Reviews Drug Discovery, Published online: 09 September 2024; doi:10.1038/d41573-024-00145-wPPAR agonists provide new treatment options for inflammatory liver disease
    Asher Mullard
  • Splice-switching ASO curtails brain calcification September 9, 2024
    Nature Reviews Drug Discovery, Published online: 09 September 2024; doi:10.1038/d41573-024-00147-8Splice-switching ASO curtails brain calcification
    Katie Kingwell
  • Neurons give metastatic cells a push September 9, 2024
    Nature Reviews Drug Discovery, Published online: 09 September 2024; doi:10.1038/d41573-024-00144-xNeurons give metastatic cells a push
    M. Teresa Villanueva

Vitreon America™ Launches Botanicopeia™ Database and Federal Government Services at NIH Festival+

 BETHESDA, MD, September 17, 2016 − Vitreon America, Inc.™ participated this week in the National Institute of Health (NIH) Intramural Research Program’s 30th Annual NIH Research Festival which was held September 15-16, 2016 at the NIH Bethesda, Maryland campus.

The Festival included plenary sessions, symposia, exhibits, poster sessions and tours designed to encourage sharing and learning about the exciting research taking place on NIH campus.

Vitreon America™ was selected by the Technical Sales Association (TSA) which sponsors the Research Festival Exhibit, to launch its state-of-the-art Phytochemical and Ethnobotanical database subscription services, Botanicopeia™.

Attending on behalf of Vitreon America™
were Michael Megginson, VP of Business Development (left) and Jorgen Sandberg,
CEO (right).

Vitreon America was pleased to see the interest from the NIH Institutions to utilize the Botanicopeia™ database subscriptions with many NIH researchers expressing interest in considering the Vitreon America Botanical Research Analytic services as well to optimize the Botanicopeia™ database.

Based on the NIH researchers feedback, Vitreon America has established a Botanicopeia™ database subscription service agreement and subscription service with botanical research analytic services through Marshall Communications Corporation, www.marshallcomm.com.

Vitreon America services are available through Marshall Communications Corporation (VOSB) on NIH’s Information Technology Acquisition and Assessment Center’s (NITAAC)- Government-wide Acquisition Contract (GWAC) vehicle. [Prime Contract Holder #HHSN316201500063W]

Vitreon America™ was established with the goal of commercializing their Botanicopeia™ database and botanical research analytic services for development of botanicals and phytochemicals in the creation of new medicinal products by Vitreon America Clients.

To find out more about our Services please contact us for assistance at 1-888-214-2584 or at info@vitreonamerica.com

About Vitreon America™

Vitreon AmericaTM was formed with the goal of disseminating their BotanicopeiaTM database to encourage the increased use of botanicals and phytochemicals in the creation of new medicines.

Contact Vitreon America, Inc.

Vitreon America Botanical Research Center @ Hopkins Johns Hopkins University

MCC 9601 Medical Center Drive, Suite 221
Rockville, Maryland 20850

+1-888-214-2584

j.shaver@advasur.com